SIADH has also been increasingly reported in patients with COVID-19, as well, ascribing this phenomenon to IL-6 and other mechanisms, such as pneumonia-associated ADH release and baroceptor-mediated ADH release in hypovolemic and hypotensive COVID-19 patients [43]. Here, IL6 is linked to COVID-19.